Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 17.03.2022.

#ClinicalResearchNews
#PharmiwebNews
#PharmaNews
#MedicalNews
#BiotechNews
#LifeSciencesNews
#HealthcareNews
#CRISPR
#pharma
#medicalindustry

Career And Jobs

@pharminews shared
On Mar 11, 2022
HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE https://t.co/qgZ18r8hvB #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/zmsiQpT60P
Open
HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE

HOFSETH BIOCARE AWARDED BEST SUSTAINABLE BIOTECH COMPANY 2022 ACCOLADE

Hofseth BioCare (HBC) has been named Best Sustainable Biotech Company 2022 in the Global Health & Pharma Biotechnology Awards. The award is in recognition of HBC’s 15 years of pioneering ...

@JohnCendpts shared
On Mar 16, 2022
Biotech founders sentenced to 1 year and 1 day for stealing Genentech secrets, lying to investors By @AmberTongPW https://t.co/JkodzcEmDE
Open
Biotech founders sentenced to 1 year and 1 day for stealing Genentech secrets, lying to investors

Biotech founders sentenced to 1 year and 1 day for stealing Genentech secrets, lying to investors

The founders of the biosimilar developer who pleaded guilty to stealing trade secrets from Genentech will be imprisoned for a year and one day. Racho Jordanov and Rose Lin were the CEO and ...

@JohnCendpts shared
On Mar 16, 2022
Back to the fundamentals: Frazier rolls out $1B fund to ramp up a new slate of biotech startups By @PaulSchloesser https://t.co/nohvgfa9Ft
Open
Back to the fundamentals: Frazier rolls out $1B fund to ramp up a new slate of biotech startups

Back to the fundamentals: Frazier rolls out $1B fund to ramp up a new slate of biotech startups

Less than a year after Frazier Healthcare Partners debuted an $830 million public fund for life science investments, the VC is back with even more cash — with a focus on early biotechs in ...

@GENbio shared
On Mar 15, 2022
.@thermofisher said it will add 500 people to its workforce in and around Richmond, VA, through a $97 million expansion of clinical research operations it inherited when it completed its $17.4 million acquisition of PPD in December. Learn more: https://t.co/ngYno7nHLj https://t.co/LTUbpVpRj8
Open
Thermo Fisher Adding 500 Jobs in Richmond, VA-Area CRO Expansion

Thermo Fisher Adding 500 Jobs in Richmond, VA-Area CRO Expansion

Thermo Fisher Scientific said it will add 500 people to its workforce in and around Richmond, VA, through a $97 million expansion of clinical research operations it inherited when it ...

@JohnCendpts shared
On Mar 16, 2022
A fine, thoughtful piece on Sanofi's pricing strategy for its RSV antibody, from @Jasonmmast https://t.co/qhqbzbUX4J
Open
With new RSV antibody, Sanofi looks to avoid a repeat of a 20-year-old pricing controversy

With new RSV antibody, Sanofi looks to avoid a repeat of a 20-year-old pricing controversy

Twenty-four years ago, the FDA approved a drug as controversial as it was innovative. Known as Synagis, it was OK’d for protecting certain infants against respiratory syncytial virus, or ...

@BuiltWithBio shared
On Mar 14, 2022
Meet @janiceschen, the 30-year-old female founder at the forefront of a billion-dollar bet on #CRISPR gene editing https://t.co/LoVXEyCMDR @mammothbiosci
Open
The 30-year-old female founder at the forefront of a billion-dollar bet on CRISPR gene editing

The 30-year-old female founder at the forefront of a billion-dollar bet on CRISPR gene editing

Nathan Chen’s sister Janice co-founded Mammoth Biosciences while watching her brother skate in the Olympics. Her plan: get the CRISPR start-up to $100 billion.

@biospace shared
On Mar 11, 2022
The drop in value has prompted @MorphoSys to make drastic changes, such as discontinuing its U.S. operations and abandoning several pipeline projects. #pharma #medicalindustry https://t.co/YRy2RBk5Qr
Open
MorphoSys Eats $250M, Centralizes Operations in Germany

MorphoSys Eats $250M, Centralizes Operations in Germany

The drop in value has prompted MorphoSys to make drastic changes, such as discontinuing its U.S. operations and abandoning several pipeline projects. 

@pharminews shared
On Mar 16, 2022
Toxys Opens US Office and Production Facility to Accelerate Growth https://t.co/RIwTLv1NiU #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/fqhqiqlazu
Open
Toxys Opens US Office and Production Facility to Accelerate Growth

Toxys Opens US Office and Production Facility to Accelerate Growth

OEGSTGEEST, the Netherlands, March 16, 2022 / B3C newswire / -- Toxys BV, a Dutch biotech company that offers a broad spectrum of innovative in vitro toxicology solutions for the safety ...